From the ultra-rapid diagnosis of a heart attack to the prognosis of breast cancer recurrence, how French companies are innovating in medical tests
The launch of the new BioMérieux laboratory test to diagnose a heart attack in a few minutes highlights the dynamism of the French in vitro diagnostics industry, which produces faster, less invasive tests that can provide more information.
We haven't written up this one. Le Monde Economie has the full story — the link below goes straight to it.
